Insulin-Derived Cutaneous Amyloidosis: A Possible Complication of Repeated Insulin Injections
- Author:
Hyeon Jeong PARK
1
;
Won-Serk KIM
;
Seung-Wan CHAE
;
Young-Jun CHOI
Author Information
- Publication Type:Case Report
- From:Annals of Dermatology 2023;35(Suppl1):S71-S75
- CountryRepublic of Korea
- Language:English
- Abstract: Primary localized cutaneous amyloidosis (PLCA) is characterized by extracellular deposition of pathological fibril aggregation of proteins in the skin without systemic involvement.Macular amyloidosis, lichen (papular) amyloidosis, and nodular amyloidosis are three different subtypes of PLCA. Although the pathological mechanism of PLCA has not yet been clarified, it is assumed that a nucleus formation of amyloid fibril is formed due to repeated external stimulation, such as subcutaneous injection, which often poses diagnostic challenges. Herein, we present a 54-year-old Korean male patient with cutaneous localized amyloidosis which occurred after repeated local insulin injections, and discuss the relationship between insulin therapy in patients with diabetes mellitus and dermal amyloid deposition.
